Prescription and Persistence of Antithrombotic Agents in Acute Ischemic Stroke or Transient Ischemic Attack Patients With MCA(Middle Cerebral Artery) Disease

• Conditions: MCA - Middle Cerebral Artery Dissection

• Registration Number: NCT02953405
• Lead Sponsor: Daewoong Pharmaceutical Co. LTD.

Brief Summary

Prescription and Persistence of Antithrombotic agents in Acute Ischemic Stroke or Transient Ischemic Attack Patients with MCA(Middle Cerebral Artery) Disease.

Detailed Description

Not available

Study Timeline

• Study Start: 2015-12
• Status Verified: 2016-10
• Study First Submitted: 2016-10-25
• Study First Submitted QC: 2016-11-01
• Last Update Submitted: 2016-11-01
• Study First Posted: 2016-11-02
• Last Update Posted: 2016-11-02
• Primary Completion: 2018-11
• Study Completion: 2018-11

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 1000

Inclusion Criteria

• 19 years later, men and women

Exclusion Criteria

• Subject who is judged to be ineligible by investigator

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Prescription status of Antithrombotic Agents	at 12 months after baseline(onset)

Trial Locations

Locations (1)

SNUBH; 🇰🇷 Seoul, Korea, Republic of